Current Ratio of CRISPR Therapeutics AG from 30 Jun 2017 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
CRISPR Therapeutics AG quarterly Current Ratio in % history and change rate from 30 Jun 2017 to 30 Sep 2025.
  • CRISPR Therapeutics AG Current Ratio for the quarter ending 30 Sep 2025 was 1734%, a 3.2% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

CRISPR Therapeutics AG Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 1734% -58% -3.2% 30 Sep 2025
Q2 2025 1864% +194% +12% 30 Jun 2025
Q1 2025 1826% +205% +13% 31 Mar 2025
Q4 2024 1888% +399% +27% 31 Dec 2024
Q3 2024 1792% +350% +24% 30 Sep 2024
Q2 2024 1671% +301% +22% 30 Jun 2024
Q1 2024 1621% +173% +12% 31 Mar 2024
Q4 2023 1488% -124% -7.7% 31 Dec 2023
Q3 2023 1442% -287% -17% 30 Sep 2023
Q2 2023 1369% -699% -34% 30 Jun 2023
Q1 2023 1448% -837% -37% 31 Mar 2023
Q4 2022 1613% -740% -31% 31 Dec 2022
Q3 2022 1728% -598% -26% 30 Sep 2022
Q2 2022 2069% -23% -1.1% 30 Jun 2022
Q1 2022 2285% +527% +30% 31 Mar 2022
Q4 2021 2353% +729% +45% 31 Dec 2021
Q3 2021 2326% +749% +47% 30 Sep 2021
Q2 2021 2092% +761% +57% 30 Jun 2021
Q1 2021 1758% +406% +30% 31 Mar 2021
Q4 2020 1624% +333% +26% 31 Dec 2020
Q3 2020 1578% +371% +31% 30 Sep 2020
Q2 2020 1331% -214% -14% 30 Jun 2020
Q1 2020 1352% -279% -17% 31 Mar 2020
Q4 2019 1291% -480% -27% 31 Dec 2019
Q3 2019 1206% -585% -33% 30 Sep 2019
Q2 2019 1545% -453% -23% 30 Jun 2019
Q1 2019 1631% -374% -19% 31 Mar 2019
Q4 2018 1771% -57% -3.1% 31 Dec 2018
Q3 2018 1791% +61% +3.5% 30 Sep 2018
Q2 2018 1998% +1148% +135% 30 Jun 2018
Q1 2018 2005% 31 Mar 2018
Q4 2017 1827% 31 Dec 2017
Q3 2017 1730% 30 Sep 2017
Q2 2017 850% 30 Jun 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.